Reference
·Primary source
Thailand pharmaceutical manufacturing factory-gate revenue (2020-2024)
~THB 92B (2024)
Thailand pharmaceutical manufacturing factory-gate revenue (output value sold by domestic manufacturers) reached approximately THB 92 billion in 2024 per Thai FDA and Pharmaceutical Research and Manufacturers Association of Thailand (PReMA) data, up from THB 78 billion in 2020. The 2021-2022 lift reflected COVID-era demand for analgesics, antivirals (favipiravir local production), and vaccine fill-finish at Siam Bioscience. Krungsri Research projects 6-7% annual growth through 2027 on generic substitution, aging-population chronic disease demand, and BOI Future Medicine investment commitments locating biopharmaceutical capacity in Thailand.
Figure in context
Thailand pharmaceutical manufacturing factory-gate revenue (output value sold by domestic manufacturers) reached approximately THB 92 billion in 2024 per Thai FDA and Pharmaceutical Research and Manufacturers Association of Thailand (PReMA) data, up from THB 78 billion in 2020. The 2021-2022 lift reflected COVID-era demand for analgesics, antivirals (favipiravir local production), and vaccine fill-finish at Siam Bioscience. Krungsri Research projects 6-7% annual growth through 2027 on generic substitution, aging-population chronic disease demand, and BOI Future Medicine investment commitments locating biopharmaceutical capacity in Thailand.
Interpretation notes
What this tells you
Thailand pharmaceutical manufacturing factory-gate revenue (output value sold by domestic manufacturers) reached approximately THB 92 billion in 2024 per Thai FDA and Pharmaceutical Research and Manufacturers Association of Thailand (PReMA) data, up from THB 78 billion in 2020. The 2021-2022 lift reflected COVID-era demand for analgesics, antivirals (favipiravir local production), and vaccine fill-finish at Siam Bioscience. Krungsri Research projects 6-7% annual growth through 2027 on generic substitution, aging-population chronic disease demand, and BOI Future Medicine investment commitments locating biopharmaceutical capacity in Thailand.
What not to do with it
Values in THB billion factory-gate. Excludes imported finished products distributed in Thailand.
Related figures
Adjacent numbers that add context without drowning the value.
Thailand pharmaceutical generic vs branded mix (2024)
PReMA, IQVIA Thailand, Thai FDA, Government Pharmaceutical Organization
Thailand pharmaceutical manufacturer revenue share (2024)
PReMA, Thai FDA, GPO annual report, Mega Lifesciences, industry estimates
BOI Future Medicine approved projects (2020-2024)
Thailand Board of Investment, BOI Future Medicine sector briefing, NESDC
Thailand FDA GMP-certified pharmaceutical facility count (2024)
Thai FDA Drug Control Division, PIC/S accession documentation, PReMA, industry estimates
Siam Bioscience vaccine output capacity (2024)
Siam Bioscience disclosures, PReMA, Bangkok Post pharma coverage, WHO prequalification listing
Thailand pharma facilities with EU GMP cross-certification (2024)
Thai FDA, EudraGMDP database, PReMA, operator disclosures
Report context
Atlas actors in this figure's reports
Profiles covered in the report that cite this number.